Placebo (R = 1) Cholestyramine Treatment (R = 0)   Cholesterol ≥ 280 mg/dL (D = 1) Cholesterol < 280 mg/dL (D = 0) Total Placebo Cholesterol ≥ 280 mg/dL (D = 1) Cholesterol < 280 mg/dL (D = 0) Total Treatment Y = 1   82     86   168   33     97   130 Y = 0 669 1081 1750 332 1426 1758 Total 751 1167 1918 365 1523 1888

Table 1: Definite CHD mortality or myocardial infarction events (Y) in the LRCCPPT according to randomized cholestyramine treatment group (R) and serum cholesterol (mg/dL) at 1 year (D) [27].